{2-[2-((S)-1-Phenyl-propylamino)-pyridin-4-yl]-thieno[3,2-d]pyrimidin-4-yl}-(R)-pyrrolidin-3-yl-amine

ID: ALA3728040

PubChem CID: 89596471

Max Phase: Preclinical

Molecular Formula: C24H26N6S

Molecular Weight: 430.58

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC[C@H](Nc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1)c1ccccc1

Standard InChI:  InChI=1S/C24H26N6S/c1-2-19(16-6-4-3-5-7-16)28-21-14-17(8-12-26-21)23-29-20-10-13-31-22(20)24(30-23)27-18-9-11-25-15-18/h3-8,10,12-14,18-19,25H,2,9,11,15H2,1H3,(H,26,28)(H,27,29,30)/t18-,19+/m1/s1

Standard InChI Key:  KBFQPRXCRFSETO-MOPGFXCFSA-N

Molfile:  

     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
   -1.0028   -1.5132    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9971    3.0138    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2917    0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2917   -0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7138   -1.2033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3155    0.7475    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3155   -0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7138    1.2033    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2151   -1.4892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6204   -2.9950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9144   -0.7421    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9211   -3.7421    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2935    3.7700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0028    1.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2185   -2.9892    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5889    0.0182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6168   -1.4950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4279    5.2511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8944    5.5664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6474    4.2692    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6464    3.1521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9214   -5.2429    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6222   -5.9944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6225   -7.4952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3252   -8.2482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3285   -9.7482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6292  -10.4953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9266   -9.7424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9232   -8.2424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3206   -5.2473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2825   -5.8493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  4  1  1  0
  6 14  2  0
  5  4  1  0
  8 16  1  0
  4  3  2  0
 17 11  2  0
  3  8  1  0
 15 12  1  0
 16  5  2  0
 14  2  1  0
  1  7  2  0
 12 10  2  0
 13  2  1  1
 10 17  1  0
  9 15  2  0
 14  3  1  0
 11  9  1  0
  7 17  1  0
  7  6  1  0
 13 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 13  1  0
 12 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 23 30  1  1
 30 31  1  0
M  END

Associated Targets(Human)

PRKCI Tchem Protein kinase C iota (2821 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 430.58Molecular Weight (Monoisotopic): 430.1940AlogP: 5.09#Rotatable Bonds: 7
Polar Surface Area: 74.76Molecular Species: BASEHBA: 7HBD: 3
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 10.31CX LogP: 4.96CX LogD: 2.18
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.38Np Likeness Score: -1.47

References

1.  (2013)  Thienopyrimidine inhibitors of atypical protein kinase C, 

Source